keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Canagliflozin (JNJ 28431754AAA) 是SGLT2的选择性抑制剂,在表达 mSGLT2,rSGLT2 和 hSGLT2 的 CHO 细胞上,IC50分别为 2 nM,3.7 nM 和 4.4 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 185 | 现货 | ||
5 mg | ¥ 413 | 现货 | ||
10 mg | ¥ 622 | 现货 | ||
50 mg | ¥ 813 | 现货 | ||
100 mg | ¥ 987 | 现货 | ||
200 mg | ¥ 1,530 | 现货 | ||
500 mg | ¥ 2,580 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 455 | 现货 |
产品描述 | Canagliflozin (JNJ 28431754AAA), a sodium-glucose transporter 2( SGLT2) and P-Glycoprotein inhibitor, is used in type 2 diabetes. |
靶点活性 | SGLT2 (rat):3.7 nM, SGLT2 (mouse):2 nM, SGLT2 (human):4.4 nM |
体外活性 | 在注射SGLT3-的卵母细胞中,Canagliflozin(10 μM)能够抑制DNJ诱导的电流。在CHO-hSGLT1细胞(IC50=0.7 μM) 和mSGLT1 细胞(IC50=>1 μM)中,Canagliflozin抑制 14C-AMG 吸收。在L6成肌细胞中,Canagliflozin抑制(非-Na+-关联的) GLUT调节的2H-2-DG吸收。 |
体内活性 | 在高糖高脂肪饲料喂养的KK小鼠中,单独口服 Canagliflozin(3 mg/kg)具有明显的抗高血糖效果.在雄性SD大鼠中,口服 Canagliflozin(30 mg/kg)能够诱导葡萄糖外排,降低血糖水平. |
细胞实验 | Cells from the rat skeletal muscle cell line, L6, is used to test the effect of Canagliflozin on glucose transporter 1 (GLUT1) activity. Cells are maintained in Dulbecco's modified Eagle's medium containing 5.6 mM glucose supplemented with 10% fetal bovine serum, are seeded in 24-well plates at a density of 3 × 105 cells/well and cultured for 24 hours in an atmosphere of 5% CO2 at 37 °C. Cells are rinsed twice with Kreb's ringer phosphate HEPES buffer (pH 7.4, 150 mM NaCl, 5 mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 2.9 mM Na2HPO4, 10 mM HEPES) and are pre-incubated with the solutions of Canagliflozin (250 μL, 10 μM) for 5 minutes at room temperature. The transport reaction is initiated by adding 50 μL of 4.5 mM 2-DG (a substrate for GLUTs)/3H-2-DG (0.625 μCi) followed by incubation for 15 minutes at room temperature. The 2-DG uptake is halted by aspiration of the incubation mixture. Cells are immediately washed 3 times with ice-cold PBS. Samples are extracted with 0.3 N NaOH, and radioactivity is determined by liquid scintillation.(Only for Reference) |
别名 | 卡格列净, JNJ 24831754ZAE, JNJ 28431754AAA, TA 7284, JNJ 28431754 |
分子量 | 444.52 |
分子式 | C24H25FO5S |
CAS No. | 842133-18-0 |
keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 82 mg/mL (184.5 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2496 mL | 11.2481 mL | 22.4962 mL | 56.2404 mL |
5 mM | 0.4499 mL | 2.2496 mL | 4.4992 mL | 11.2481 mL | |
10 mM | 0.225 mL | 1.1248 mL | 2.2496 mL | 5.624 mL | |
20 mM | 0.1125 mL | 0.5624 mL | 1.1248 mL | 2.812 mL | |
50 mM | 0.045 mL | 0.225 mL | 0.4499 mL | 1.1248 mL | |
100 mM | 0.0225 mL | 0.1125 mL | 0.225 mL | 0.5624 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Canagliflozin 842133-18-0 GPCR/G Protein SGLT Sodium-dependent glucose cotransporters 卡格列净 TA-7284 JNJ 24831754ZAE JNJ 28431754AAA TA 7284 JNJ-28431754 Inhibitor JNJ 28431754 inhibit JNJ28431754 TA7284 inhibitor